Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP.
about
Androgen receptor molecular biology and potential targets in prostate cancerRhoA as a mediator of clinically relevant androgen action in prostate cancer cellsMAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancerLoss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesisAndrogen Receptor Exon 1 Mutation Causes Androgen Insensitivity by Creating Phosphorylation Site and Inhibiting Melanoma Antigen-A11 Activation of NH2- and Carboxyl-terminal Interaction-dependent TransactivationGain in Transcriptional Activity by Primate-specific Coevolution of Melanoma Antigen-A11 and Its Interaction Site in Androgen ReceptorFunctional interaction between co-expressed MAGE-A proteinsRegulation of cancer germline antigen gene expression: implications for cancer immunotherapy.Transcriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling.Oxidative stress and DNA methylation in prostate cancer.5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators.Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone.Structural features discriminate androgen receptor N/C terminal and coactivator interactions.The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptorInhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesA competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genesPost-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.Primate-specific melanoma antigen-A11 regulates isoform-specific human progesterone receptor-B transactivation.Cancer/testis antigens and urological malignanciesNuclear receptor coactivators: structural and functional biochemistry.Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteinsDNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11.Emerging biological observations in prostate cancer.The role of intracrine androgen metabolism, androgen receptor and apoptosis in the survival and recurrence of prostate cancer during androgen deprivation therapy.Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers.The biology of cancer testis antigens: putative function, regulation and therapeutic potentialHypomethylating agents for urologic cancers.Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC).The MAGE protein family and cancer.Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus.Lost miRNA surveillance of Notch, IGFR pathway--road to sarcomagenesis.A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases.Rationale for the development of alternative forms of androgen deprivation therapy.MAGE-D4B is a novel marker of poor prognosis and potential therapeutic target involved in breast cancer tumorigenesis.Transgelin induces apoptosis of human prostate LNCaP cells through its interaction with p53.
P2860
Q24602861-200DAF60-12B3-41A3-A9B3-BAA74F432608Q24618899-61D5EC47-6383-4635-A406-3A11514B30D6Q28478930-CB565245-33BF-4A04-B3DE-8B3C14B7ADFDQ28589092-08D6A2FF-4726-4A5C-87C8-6B01032FA7A9Q29036974-C68A8813-890B-4236-991E-B17B822A603BQ29040033-0F9441D9-5025-4B27-AF18-58B63E261778Q33725090-AEC37271-B200-425F-BB94-67D15D727170Q33957165-3CF205D3-75A7-450C-B668-5A6727B1FD5AQ33967239-C93FB930-B34E-483B-8D3B-3777142687C1Q34021985-AB0D1A6C-AFCE-4DCC-A986-75F2E3741505Q34183936-0133167C-1FA7-4862-AF64-3EA221671F39Q34196069-E009BE28-66F3-4287-AF12-2961DD6336A7Q34313140-8778465D-BC56-4E9A-A32D-09D4EE05B3D5Q34786897-0CCC9269-76D8-457D-B80F-17C9987F888DQ35007914-9EA31472-2424-4DD6-81FD-DB88C6B256E5Q35223874-9C4E9002-17C5-4891-8627-4EAD8A02F665Q35417636-EFD166C0-A009-46C3-8A13-8B11DBE2CE4DQ35838409-29E6545E-BFE4-4CD4-91FA-231B4E087092Q36015063-D5B3B0B9-F418-41CE-9192-31863FAF54C5Q36078731-C19FEBBB-92B6-4DD6-AB56-D7831322D516Q36139948-3E0B4190-99CD-491E-84DA-5149BDD5D6E5Q36298532-B6BBD2CC-821F-47F3-B373-3FFE4F23E55BQ36337004-5554BCFA-4554-47DC-AC5F-2BFD7BCF3967Q36826106-A459EDB0-8B42-487E-8369-1B296DC51190Q37112738-C1A63513-3F26-4414-822B-966FCB934762Q37445288-BF77C864-49C5-48ED-86D0-AF4BBEEFFFCFQ37656229-1E156450-F661-4BF9-925F-63B726615A59Q37709925-12F4184A-8947-41C5-9052-E9DD7C0C676DQ37718427-82656E31-0BA6-435F-825A-C8A75A9FF673Q37849976-CDC585F1-6CD2-447D-B788-2DC3B55C5090Q37854737-8B30F9F0-3174-4E5E-9F26-8E93763448FCQ38044064-A3285AFD-130E-479B-8076-F77A6FAEF1D5Q38581531-D614ADF8-A372-4FDC-BAED-6E22068140E6Q38948541-645B1BBC-7A7D-45D8-AC62-08D448C626C5Q39073923-3F55F519-54D3-48D5-802F-206341943A72Q39108056-E09B7D05-296E-45BB-AD6C-F82246C52297Q39181769-71F4B629-6EAD-4CF3-9A5C-61C42EB8E9F0Q39342369-16A73D01-CE34-4088-9166-264B6584189BQ39535107-920F5C8A-5121-4B06-A92D-BB5EC1A96FE3Q39748548-64930DE0-4D42-4B11-AB0A-848D20E37DA6
P2860
Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased expression of androg ...... ypomethylation and cyclic AMP.
@en
Increased expression of androg ...... ypomethylation and cyclic AMP.
@nl
type
label
Increased expression of androg ...... ypomethylation and cyclic AMP.
@en
Increased expression of androg ...... ypomethylation and cyclic AMP.
@nl
prefLabel
Increased expression of androg ...... ypomethylation and cyclic AMP.
@en
Increased expression of androg ...... ypomethylation and cyclic AMP.
@nl
P2093
P2860
P1476
Increased expression of androg ...... ypomethylation and cyclic AMP.
@en
P2093
Adam R Karpf
Elizabeth M Wilson
James L Mohler
Smitha R James
P2860
P304
P356
10.1158/1541-7786.MCR-08-0400
P577
2009-04-01T00:00:00Z